← Leaderboards
Charles Daniel Leahy
Vista Scientific, Llc
$2,005,339
Attributed
$2,986,212
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $988.9K · FY2008–10$1M$750K$500K$250K$0
'08
'09
'10
Funding mix
By agency
NIH$2,986,212 · 4
By mechanism
R44$2,430,566 · 1
R43$555,646 · 3
Top collaborators
- Kathryn S Crawford2 shared
- Edward J Ellis2 shared
Others in their field
Top investigators on “Drug Delivery Systems”
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
- Myron S Cohen · Family Health International$101,800,876
- Gerald Van Belle · University Of Washington$48,120,734
- David Heimbrook · Leidos Biomedical Research, Inc.$47,325,954
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$38,382,452
- Martin Friedlander · Scripps Research Institute$36,319,942
Research focus
Drug Delivery SystemsGlaucomaPolymerizationPolymersClinical ResearchMoldsRecording Of Previous EventsSurfaceEye Disorder ChemotherapyDrug Administration Rate /DurationOphthalmic DrugPharmaceutical PreparationsManufacturing ProcessBaseBiomaterial EvaluationDevicesBiomaterial Development /PreparationDesignDoseDropsClinical TrialsEye AgentLegal PatentTechnology
Grant awards (9)
Ocular Insert for Non-Invasive Sustained Drug Delivery for the Treatment of Glauc$802,343
R44 · FY2010 · EY · contact PI
Ocular Insert for Non-Invasive Sustained Drug Delivery for the Treatment of Glauc$802,258
R44 · FY2009 · EY · contact PI
Nanosphere-Antibiotic Corneal Contact Lens Delivery System$186,614
R43 · FY2009 · EY · contact PI
Nanosphere-Antibiotic Corneal Contact Lens Delivery System$170,532
R43 · FY2008 · EY · contact PI
Overnight Orthokeratology Contact Lens Manufacture$100,000
R43 · FY2004 · EY
OCULAR INSERT FOR THE TREATMENT OF GLAUCOMA$20,398
R44 · FY2004 · EY
OCULAR INSERT FOR THE TREATMENT OF GLAUCOMA$396,073
R44 · FY2003 · EY
OCULAR INSERT FOR THE TREATMENT OF GLAUCOMA$409,494
R44 · FY2002 · EY
OCULAR INSERT FOR THE TREATMENT OF GLAUCOMA$98,500
R43 · FY2001 · EY